Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 206 entries
View as:

Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

Phase: N/A Priority: Normal
NCT ID: NCT00446134 Org: User:
Start: 03/31/07 End: 04/30/09 Due: 04/30/10

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Phase: N/A Priority: Normal
NCT ID: NCT01007448 Org: User:
Start: 01/06/10 End: 02/20/14 Due: 02/20/15

A Study of Different Use Regimens Using Two Acne Treatments

Phase: N/A Priority: Normal
NCT ID: NCT00907257 Org: User:
Start: 02/28/09 End: 09/30/09 Due: 09/30/10

Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

Phase: N/A Priority: Normal
NCT ID: NCT01366365 Org: User:
Start: 10/31/06 End: 11/30/06 Due: 11/30/07

(CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.

Phase: N/A Priority: Normal
NCT ID: NCT00801723 Org: User:
Start: 12/31/08 End: 06/30/11 Due: 06/30/12

Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00408174 Org: User:
Start: 05/31/06 End: 11/30/07 Due: 11/30/08

Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01708590 Org: User:
Start: 08/31/12 End: 08/31/15 Due: 08/31/16

PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00622375 Org: User:
Start: 02/29/08 End: 05/31/08 Due: 05/31/09

Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00724126 Org: User:
Start: 07/31/08 End: 09/30/09 Due: 09/30/10

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Phase: N/A Priority: Normal
NCT ID: NCT00326209 Org: User:
Start: 12/22/05 End: 05/05/08 Due: 05/05/09

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03003247 Org: User:
Start: 11/30/15 End: 09/30/16 Due: 09/30/17

Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring

Phase: N/A Priority: Normal
NCT ID: NCT00795327 Org: User:
Start: 10/31/08 End: 09/30/09 Due: 09/30/10

Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain

Phase: N/A Priority: Normal
NCT ID: NCT00366431 Org: User:
Start: 08/31/06 End: 03/31/07 Due: 03/31/08

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02785159 Org: User:
Start: 02/29/16 End: 12/31/16 Due: 12/31/17

A Study of Oral Methylnaltrexone (MNTX) for the Treatment of Opioid-Induced Constipation (OIC) in Participants With Chronic, Non-Malignant Pain

Phase: N/A Priority: Normal
NCT ID: NCT01186770 Org: User:
Start: 09/01/10 End: 09/08/11 Due: 09/08/12

Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00731679 Org: User:
Start: 07/31/08 End: 09/30/09 Due: 09/30/10

Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01366326 Org: User:
Start: 07/31/10 End: 08/31/10 Due: 08/31/11

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT01846663 Org: User:
Start: 04/03/13 End: 02/22/16 Due: 02/22/17

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)

Phase: N/A Priority: Normal
NCT ID: NCT00348452 Org: User:
Start: 09/30/02 End: 08/31/03 Due: 08/31/04

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04314375 Org: User:
Start: 09/29/23 End: 12/31/24 Due: 12/31/25

Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00975637 Org: User:
Start: 12/31/09 End: 09/30/10 Due: 09/30/11

Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)

Phase: N/A Priority: Normal
NCT ID: NCT03515044 Org: User:
Start: 09/13/18 End: 03/12/20 Due: 03/12/21

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02965456 Org: User:
Start: 11/04/15 End: 02/23/17 Due: 02/23/18

Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain

Phase: N/A Priority: Normal
NCT ID: NCT00529087 Org: User:
Start: 08/31/07 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01708629 Org: User:
Start: 09/30/12 End: 10/31/15 Due: 10/31/16